INNOVEX INTERNATIONAL, INC. (INVX) FY2026 Q2 Balance Sheet
As of 2026-06-30
Balance Sheet
As of 2026-06-30
Swipe to see the full flow
Chart details
INNOVEX INTERNATIONAL, INC. (INVX) FY2026 Q2 Balance Sheet
Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.
- Assets
- 1,327,747,000 US dollars
- Current assets
- 788,527,000 US dollars
- Non-current assets
- 539,220,000 US dollars
- Liabilities
- 269,248,000 US dollars
- Current liabilities
- 157,515,000 US dollars
- Non-current liabilities
- 111,733,000 US dollars
- Equity
- 1,058,499,000 US dollars
- Inventories
- 264,837,000 US dollars
- Trade receivables, net of allowance of $15,174 and $19,752 at June 30, 2026 and December 31, 2025, respectively
- 240,094,000 US dollars
- Cash and restricted cash
- 222,055,000 US dollars
- Prepaid expenses and other current assets
- 58,282,000 US dollars
- Contract assets
- 3,259,000 US dollars
- Property and equipment, net
- 169,636,000 US dollars
- Intangibles, net
- 115,326,000 US dollars
- Goodwill
- 106,005,000 US dollars
- Deferred tax asset, net
- 89,341,000 US dollars
- Right-of-use assets - operating
- 48,728,000 US dollars
- Other long-term assets
- 10,184,000 US dollars
- Accounts payable
- 77,188,000 US dollars
- Accrued expenses
- 37,755,000 US dollars
- Contract liabilities
- 14,484,000 US dollars
- Operating lease liabilities
- 12,741,000 US dollars
- Other current liabilities
- 9,304,000 US dollars
- Current portion of long-term debt and finance lease obligations
- 6,043,000 US dollars
- Legal settlement accrual
- 51,607,000 US dollars
- Operating lease liabilities
- 36,729,000 US dollars
- Long-term debt and finance lease obligations
- 19,041,000 US dollars
- Other long-term liabilities
- 3,735,000 US dollars
- Deferred income taxes
- 621,000 US dollars
- Additional paid-in capital
- 772,905,000 US dollars
- Retained earnings
- 279,511,000 US dollars
- Accumulated other comprehensive income
- 5,394,000 US dollars
- Common stock: $0.01 par value, 200,000,000 shares authorized at June 30, 2026 and December 31, 2025; 68,875,856 and 69,077,237 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
- 689,000 US dollars
- Preferred stock: 10,000,000 shares authorized at $0.01 par value (none issued)
- 0 US dollars
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
